TFF Pharmaceuticals (TFFP) News Today → Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad) Free TFFP Stock Alerts $2.06 +0.01 (+0.49%) (As of 05/31/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | globenewswire.comTFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical TestingMay 20, 2024 | globenewswire.comTFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical TestingMay 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for TFF Pharmaceuticals Amid Strong Clinical Data and Market PotentialMay 15, 2024 | globenewswire.comTFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant RejectionMay 15, 2024 | investorplace.comTFFP Stock Earnings: TFF Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024May 14, 2024 | globenewswire.comTFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate UpdateMay 1, 2024 | globenewswire.comTFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public OfferingApril 29, 2024 | globenewswire.comTFF Pharmaceuticals Announces Pricing of $4.8 Million Public OfferingApril 29, 2024 | reuters.comTurkish federation investigates match-fixing allegations in third-tier gameApril 29, 2024 | globenewswire.comTFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual MeetingApril 17, 2024 | msn.comTFF Pharmaceuticals (TFFP) Price Target Decreased by 28.99% to 24.99April 15, 2024 | markets.businessinsider.comTFF Pharmaceuticals Reports Addl. Positive Phase 2 Data For Tacrolimus Inhalation PowderApril 15, 2024 | globenewswire.comTFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract SessionsApril 1, 2024 | finance.yahoo.comTFF Pharmaceuticals Full Year 2023 Earnings: Misses ExpectationsMarch 29, 2024 | investing.comTFF Pharmaceuticals reports positive phase 2 trial resultsMarch 29, 2024 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | investorplace.comTFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023March 28, 2024 | globenewswire.comTFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | globenewswire.comTFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical ProgramsMarch 25, 2024 | globenewswire.comTFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 MeetingMarch 22, 2024 | globenewswire.comTFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMarch 21, 2024 | finance.yahoo.comTFF Pharmaceuticals, Inc. (TFFP)March 20, 2024 | marketbeat.comTrading was temporarily halted for "TFFP" at 12:03 PM with a stated reason of "LULD pause."March 20, 2024 | globenewswire.comTFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMarch 20, 2024 | globenewswire.comTFF Pharmaceuticals Announces Update on Clinical ProgramsMarch 14, 2024 | globenewswire.comTFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024March 12, 2024 | uk.investing.comTff Pharmaceuticals Inc (TFFP)February 29, 2024 | marketbeat.comTrading was temporarily halted for "TFFP" at 09:02 AM with a stated reason of "LULD pause."January 24, 2024 | finance.yahoo.comTFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis ConferenceJanuary 9, 2024 | finance.yahoo.comTFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 MeetingJanuary 5, 2024 | morningstar.comTFF Pharmaceuticals Inc Ordinary SharesDecember 21, 2023 | markets.businessinsider.comPositive Phase II Results Bolster Buy Rating for TFF Pharmaceuticals with Raised Price TargetDecember 19, 2023 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 19, 2023 | markets.businessinsider.comTFF Pharma Reveals Positive Initial Data From Ongoing Phase 2 Trials Of TFF VORI And TFF TACDecember 19, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 19, 2023 | marketbeat.comTrading was temporarily halted for "TFFP" at 07:12 PM with a stated reason of "News pending."December 18, 2023 | finance.yahoo.comTFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 15, 2023 | markets.businessinsider.comTFF Declares Reverse Stock Split For 1 Post-split Share For Every 25 Pre-split SharesDecember 15, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Reverse Stock SplitNovember 30, 2023 | finance.yahoo.comTFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of DirectorsNovember 27, 2023 | finance.yahoo.comTFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023November 23, 2023 | morningstar.comTFF Pharmaceuticals Inc Ordinary Shares TFFPNovember 21, 2023 | msn.comTFF Pharmaceuticals files for $100M mixed shelfNovember 21, 2023 | markets.businessinsider.comBuy Rating Reaffirmed for TFF Pharmaceuticals: Promising Clinical Trials and Sufficient Funding ForecastedNovember 17, 2023 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 16, 2023 | finance.yahoo.comTFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comTFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 8, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film FreezingNovember 7, 2023 | finance.yahoo.comTFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023October 2, 2023 | finance.yahoo.comTFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 Vaccines Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. TFFP Media Mentions By Week TFFP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TFFP News Sentiment▼1.890.77▲Average Medical News Sentiment TFFP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TFFP Articles This Week▼11▲TFFP Articles Average Week Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RedHill Biopharma News Today Unity Biotechnology News Today Aprea Therapeutics News Today NanoViricides News Today TherapeuticsMD News Today Aptorum Group News Today Acasti Pharma News Today Lisata Therapeutics News Today Forte Biosciences News Today Apollomics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TFFP) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
